Literature DB >> 1403516

Management of catastrophic neonatal midgut volvulus with a silo and second-look laparotomy.

M A Hoffman1, C L Johnson, T Moore, R H Pearl.   

Abstract

The case of a neonate with midgut volvulus and severe intestinal ischemia extending from the ligament of Treitz to the midtransverse colon is presented. Management consisted of abdominal silo application at the initial exploration to obviate the adverse physiological consequences of increased intraabdominal pressure from reperfusion edema of the intestine. The majority of the intestine was salvaged, and a short segment of ileum was resected. This method of treatment resulted in optimal ventilatory status, renal function, and cardiac performance. The advantages of temporary prosthetic wound coverage in selected cases of midgut volvulus include greater physiologic stability through the avoidance of "intraabdominal hypertension" and the ability to monitor the status of the intestine at the bedside.

Entities:  

Mesh:

Year:  1992        PMID: 1403516     DOI: 10.1016/0022-3468(92)90291-e

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Use of a silicone patch in the management of severe ischemic small bowel volvulus.

Authors:  Agnes Dahl-Farhoumand; J Birraux; A Darani; B E Wildhaber
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

2.  Full-thickness small intestine necrosis with midgut volvulus, distributed in a patchy fashion, is reversible with moderate blood flow: resumption of normal function to non-viable intestine.

Authors:  Hizuru Amano; Hiroo Uchida; Hiroshi Kawashima; Yujiro Tanaka; Hiroshi Kishimoto
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

3.  Planned Second look laparotomy in neonatal volvulus - A safe approach for bowel salvage.

Authors:  Iftikhar Ahmad Jan; Mishail Ziaullah; Laila Obaid Obaid; Mokhatar Ali Hassan; Mona Al Shehhi
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.